Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Trace Elements, Single-dose Amino Acid Solution, Parenteral Lipid Emulsion), By Region (North America, APAC), And Segment Forecasts, 2022 - 2030

Parenteral Nutrition Market Growth & Trends

The global parenteral nutrition market size is expected to reach USD 10.7 billion by 2030 and is expected to expand at a CAGR of 6.0% over the forecast period, according to a new report by Grand View Research, Inc. Growing incidences of chronic diseases, such as cancer, diabetes, and other neurological conditions; surge in essential nutrition deficiency among critically ill patients; and growing awareness pertaining to hospital-related malnutrition are few key factors increasing the adoption of parenteral nutrition. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth. However, the high risk of infection during administration and growing preference for enteral nutrition among patients are major factors restricting the market growth.

With the increasing population, healthcare costs and food expenditure for a household and the nation are growing. Hence, a higher birth rate is expected to impact nutrition level, thereby acting as a driver for the market. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth. Realized natality has been growing in the last decade and is anticipated to maintain growth over the forecast period. In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) is 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8.0%, thereby boosting the demand for PN products worldwide.

Parenteral Nutrition Market Report Highlights

• Key players operating in the market are mainly focused on enhancing patient safety. Companies are also focusing on advancing their PN products to complement the parenteral nutrition compounding by incorporating technologies, such as barcode‐assisted medication
• The ability to provide improved lipid and protein formulations to patients is one of the key parameters that companies leverage to differentiate their products from competitors.
• Also, high infection rate, poor water quality and sanitation facilities, and lack of awareness are prevalent factors increasing the incidence of malnourishment in developing nations, which creates a significant demand for PN sources, thereby aiding market growth
• The single-dose amino acid solution nutrient type segment dominated the market in 2021 due to the introduction of newly available amino acid solutions with minimal side effects
• North America dominated the global market in 2021 owing to the rising incidence of chronic conditions & malnutrition, coupled with increasing U.S. FDA approvals in the region

Profiled Companies

B. BRAUN MELSUNGEN AG
FRESENIUS KABI AG
ALLERGAN
GRIFOLS, S.A.
PFIZER, INC.(HOSPIRA)
OTSUKA PHARMACEUTICAL FACTORY, INC.
BAXTER
ACULIFE (NIRLIFE)
SICHUAN KELUN PHARMACEUTICAL CO., LTD
VIFOR PHARMA

Please note The report will be delivered in 2-3 business days upon order notification.